Kevin N. Sheth MD, FAHA, FCCM, FNCS, FAAN, FANA
Dr. Kevin Sheth graduated from Johns Hopkins University and the University of Pennsylvania School of Medicine. He was an intern at Brigham and Women's Hospital and a neurology chief resident at Partners Neurology (Massachusetts General and Brigham & Women's Hospitals). After a fellowship in vascular neurology and neuro-critical care at Harvard, he was appointed the first neurology trained neurointensivist at the R Adams Cowley Shock Trauma Center. He was recruited to Yale as the founding chief of the Division of Neurocritical Care and Emergency Neurology. His interests are in the advancement of therapies of patients with devastating acute neurological syndromes, especially those complicated by brain swelling and hemorrhage. He is a nationally recognized clinical and translational scientist and has directed a number of multicenter studies testing potential novel therapies against brain swelling, stroke, and hemorrhage. He is the winner of the prestigious Robert Siekert Award from the American Heart Association (AHA) and the Derek Denny Brown Award from the American Neurological Association , and his research has been funded by the NIH, American Academy of Neurology, AHA, and the US Army. Dr. Sheth is the author of over 120 publications in critical care neurology and stroke. He serves on six editorial boards including the journals Stroke, Neurocritical Care, Neurology and Neurosurgery and has served on study sections for the NIH, AHA, FDA and NASA. He has formed exciting partnerships with entrepreneurs, pharmaceutical companies, medical device start-ups, and academic collaborators in order to bring forward highly innovative solutions. This effort has resulted in extensive knowledge of FDA pathways, development of phase I-III drug programs, and implementation of new technology into the clinical workspace. His highly collaborative work is dedicated to the improved understanding of neurological disease in the critically ill.